APA (7th ed.) Citation

Poordad, F., Lawitz, E., Reddy, K., Afdhal, N., Hezode, C., Zeuzem, S., . . . Sulkowski, M. (2012). 1419 A RANDOMIZED TRIAL COMPARING RIBAVIRIN DOSE REDUCTION VERSUS ERYTHROPOIETIN FOR ANEMIA MANAGEMENT IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C RECEIVING BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN. Journal of Hepatology, 56(s2), S559. https://doi.org/10.1016/S0168-8278(12)61430-5

Chicago Style (17th ed.) Citation

Poordad, F.F, et al. "1419 A RANDOMIZED TRIAL COMPARING RIBAVIRIN DOSE REDUCTION VERSUS ERYTHROPOIETIN FOR ANEMIA MANAGEMENT IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C RECEIVING BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN." Journal of Hepatology 56, no. s2 (2012): S559. https://doi.org/10.1016/S0168-8278(12)61430-5.

MLA (9th ed.) Citation

Poordad, F.F, et al. "1419 A RANDOMIZED TRIAL COMPARING RIBAVIRIN DOSE REDUCTION VERSUS ERYTHROPOIETIN FOR ANEMIA MANAGEMENT IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C RECEIVING BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN." Journal of Hepatology, vol. 56, no. s2, 2012, p. S559, https://doi.org/10.1016/S0168-8278(12)61430-5.